Erin Gibson, PhD

Stanford University

Erin Gibson received her PhD from the University of California, Berkeley in 2011 studying the role of the circadian system in homeostatic processes, including neuroendocrine, immune and neural stem cell regulation. As a postdoctoral scholar in the lab at Stanford University, Dr. Gibson studied the effect of in vivo neuronal activity on myelin microstructure in health and disease such as in the dysmyelinating disorder associated with chemotherapy-related cognitive impairment. Her lab focuses on understanding how glial cells modulate neural circuits throughout development and in diseases such as chemotherapy-related cognitive impairment, autism, and multiple sclerosis.